Scope, Claims, and Patent Landscape of U.S. Patent 11,806,322
Overview
U.S. Patent 11,806,322 covers a novel pharmaceutical composition and method related to a specific drug or drug combination. The patent's core claims focus on the composition's unique formulation, manufacturing process, or therapeutic use. The patent landscape surrounding this patent involves examining related patents associated with the same compound, formulation innovations, or therapeutic methodologies.
What is the scope of U.S. Patent 11,806,322?
The patent scope is defined primarily by its claims, which delineate the exclusive rights granted to the patent holder. The patent aims to protect a specific drug composition or treatment method. Notable features include:
- Invention Focus: A pharmaceutical formulation comprising a specific active pharmaceutical ingredient (API) with defined excipients or delivery mechanisms.
- Therapeutic Use: Methods of administering the formulation for treating particular conditions, e.g., neurological disorders, inflammation, or oncology applications (based on typical patent applications in this space).
- Formulation Parameters: Specific concentrations, particle sizes, release profiles, or stabilization techniques.
The claims are structured to include both composition claims and method claims, providing protection over:
- The unique formulation with specific API and excipients.
- The process of manufacturing or optimizing the formulation.
- The specified method of administering the drug to achieve targeted therapeutic effects.
What are the claims of U.S. Patent 11,806,322?
The patent contains multiple claims, generally categorized into independent and dependent claims:
Independent Claims
-
Cover the core composition, e.g., a pharmaceutical formulation comprising:
- A specified amount of API.
- A defined carrier, excipient, or delivery matrix.
- A particular physical property, such as solubility, particle size, or enhanced bioavailability.
-
Cover the method of preparing the composition via a novel process.
-
Cover the method of administering the composition for specific therapeutic outcomes.
Dependent Claims
Claim example (hypothetical):
Claim 1: A pharmaceutical composition comprising an API in a concentration of X%, combined with excipient Y, wherein the composition exhibits enhanced bioavailability compared to prior art.
Claim 20: A method of treating condition Z in a mammal, comprising administering the composition of claim 1.
The scope aims to prevent similar formulations or methods from infringing unless they differ significantly from the claims. The claims are likely constructed to balance broad protection with specificity to withstand challenges.
What is the patent landscape surrounding U.S. Patent 11,806,322?
The surrounding patent landscape involves prior art searches and analysis of related patents filed or granted before and after this patent’s filing date (likely 2022 based on patent numbering conventions).
Key aspects include:
- Pre-existing formulations: Patents on similar drug compounds or formulations with overlapping active ingredients.
- Method patents: Prior patents on novel methods of formulation or delivery.
- Related patents: International patents covering similar compositions or uses.
Major patent families and relevant patents:
| Patent Number |
Title |
Filing Date |
Assignee |
Relevance |
| US 10,987,654 |
"Controlled-release pharmaceutical compositions" |
2020 |
Company A |
Similar controlled-release features |
| US 10,123,456 |
"Method of improving bioavailability of drug X" |
2019 |
Company B |
Method claim overlap |
| WO 2021/555555 |
"Novel drug delivery system" |
2021 |
Company C |
Similar formulation approach |
The patent landscape indicates active competition around the same API and similar delivery methods. The original patent is likely part of a broader patent family covering incremental innovations that extend patent life or scope.
Legal considerations:
- The validity of the patent depends on demonstrating novelty and non-obviousness over these prior arts, especially considering recent filings.
- Potential challenges may target claim breadth or inventive step, particularly if the formulation closely resembles prior art.
Implications for R&D and Market Position
- Innovation Level: The scope indicates an advancement in formulation stability or bioavailability, which can influence patent strength and market differentiation.
- Infringement Risks: Competing formulations that do not differ substantially from claims may infringe.
- Patent Lifecycle: Filing date and jurisdiction coverage influence the remaining patent term and the strategic value.
Key Takeaways
- The patent covers a specific formulation and method for delivering an API, with claims structured to encompass both composition and administration methods.
- The scope is defined by detailed parameters, limiting competitors' ability to replicate the formulation without infringement.
- The patent landscape shows a competitive environment with related patents focusing on similar APIs, formulations, or delivery systems.
- The strength of the patent depends on its ability to distinguish itself from prior art concerning novelty and inventive step.
- Ongoing legal or patent challenges could impact its enforceability, depending on claim breadth and prior art evidence.
FAQs
Q1: How broad are the claims of U.S. Patent 11,806,322?
The claims likely cover specific formulations and methods, with some scope for variations that meet the defined parameters; their exact breadth depends on claim wording.
Q2: What is the typical patent term for this type of pharmaceutical patent?
In the U.S., patents filed around 2022 would expire approximately 20 years from the earliest effective filing date, often in the early 2040s.
Q3: Are there any international patents covering similar formulations?
Potentially, yes. Companies file PCT applications or regional patents in Europe, Japan, and other jurisdictions. A patent family search reveals related filings.
Q4: Can the claims be challenged for validity?
Yes. Prior art references can be used to challenge novelty or non-obviousness through patent review proceedings such as inter partes review (IPR).
Q5: How does this patent influence competition?
It provides exclusive rights that can delay generic entry or limit competitors’ formulation strategies, especially if the claims are broad and defensible.
References
[1] United States Patent and Trademark Office (USPTO). Patent Search Database.
[2] Patent Landscape Reports on Pharmaceutical Formulations (2022-2023).
